Therapeutic Effects and Associated Adverse Events of Multikinase Inhibitors in Metastatic Renal Cell Carcinoma: A Meta-Analysis

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2015.2427
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Real-World Treatment Patterns and Adverse Events in Metastatic Renal Cell Carcinoma From a Large US Claims Database

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Practical Management of Adverse Events Associated With Cabozantinib Treatment in Patients With Renal-Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2017English

Prognostic Value of Pretreatment Neutrophil Count in Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis

Cancer Management and Research
Oncology
2019English

The Safety and Serious Adverse Events of Approved ALK Inhibitors in Malignancies: A Meta-Analysis

Cancer Management and Research
Oncology
2019English

Meta-Analysis of Gene Expression and Integrin-Associated Signaling Pathways in Papillary Renal Cell Carcinoma Subtypes

Oncotarget
Oncology
2016English

Angiotensin Inhibitors as Treatment of Sunitinib/Pazopanib-Induced Hypertension in Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2017English

Meta-Analysis of Efficacy and Adverse Events of Erlotinib-Based Targeted Therapies for Advanced/Metastatic Non-Small Cell Lung Cancer

Oncotarget
Oncology
2017English

Minimal Impact on Patients’ Health Utilities Associated With Adverse Events in Metastatic Merkel Cell Carcinoma Patients on Treatment With Avelumab

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Clinicalpathological and Prognostic Significance of Survivin Expression in Renal Cell Carcinoma: A Meta-Analysis

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy